NAN
Fiscal year ends June Quarters are offset from the calendar — Q1 is Jul–Sep

Nanosonics Limited manufactures, services, and distributes ultrasound probe disinfectors and associated consumables and accessories. The company focuses on infection control and decontamination products, specifically providing reprocessing solutions for medical devices. Its primary product is the trophon ultrasound probe disinfector, which is used to clean and disinfect reusable ultrasound probes in healthcare settings. Nanosonics is also developing and commercializing endoscope reprocessing solutions, including the CORIS System, which utilizes CORIS PULSS (Pulsed Suspended Solids) technology to clean flexible endoscopes. The company serves markets in Australia, New Zealand, North America, Europe, and Asia Pacific, catering to hospitals and healthcare facilities that require infection prevention and control measures for reusable medical devices.

Summarised from the company's own disclosures, fiscal year ended Jun 2026

Industry Health Care Equipment & Services Homepage nanosonics.com.au
Sector Healthcare IR page nanosonics.com.au/investor-centre
Tags
infection control, ultrasound probes, endoscope reprocessing, medical device disinfection, biofilm removal, healthcare equipment, decontamination technology, trophon, CORIS System, CORIS PULSS, CORIS QUANTUM
Press page —

Metrics

Valuation  
Market cap A$ 846.644M
Market cap (USD) $ 569.903M
P/E 49.67
PEG —
P/BV 4.07
P/S 4.15
P/OCF 37.55
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 8.3%
ROI 8.2%
ROIC 7.4%
Profit margin 8.7%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 17.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue 203.893M 198.628M 170.012M 165.993M 120.32M 103.079M 100.054M 84.324M 60.698M 67.507M 42.796M 22.214M 21.492M 14.899M 12.301M 2.247M 763K
Net profit 17.835M 20.676M 12.972M — — — — — — — — — — — — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price 3.33 4.05 2.99 4.74 3.36 — — — — — — — — — — — —
Price performance 12m -0.18 0.35 -0.37 0.41 — — — — — — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Update - Notification of buy-back - NAN Bull 1 Bear 0 Capital return

Prompts

Nanosonics Limited (ticker NAN), listed in Australia.

ETFs Holding Nanosonics Limited

ETF Weight in ETF Shares Market value As of
AVDS 0.02% 37,818 $ 74.751K Nov 16, 2026
DFIS 0.01% 293,465 $ 565.574K Nov 12, 2026
DFIC 0.00% 119,715 $ 230.718K Nov 12, 2026
DFSI 0.00% 7,089 $ 13.662K Nov 12, 2026
DFAI 0.00% 44,437 $ 85.64K Nov 12, 2026